Related references
Note: Only part of the references are listed.Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis
H. J. Kim et al.
ONCOGENE (2009)
Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and β-Catenin/TCF Signaling
Anjali Bheda et al.
PLOS ONE (2009)
Gene expression changes during HPV-mediated carcinogenesis:: A comparison between an in vitro cell model and cervical cancer
Fang Wan et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Endoplasmic reticulum stress contributes to the cell death induced by UCH-L1 inhibitor
Yu-Yan Tan et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway
Ang Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A
Aaron Leiblich et al.
PROSTATE (2007)
The functions of UCH-L1 and its relation to neurodegenerative diseases
Rieko Setsuie et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Cell survival, cell death and cell cycle pathways are interconnected: Implications for cancer therapy
Subbareddy Maddika et al.
DRUG RESISTANCE UPDATES (2007)
Ubiquitin COOH-terminal hydrolase 1: A biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration
Barbara Seliger et al.
CLINICAL CANCER RESEARCH (2007)
RhoA protein expression correlates positively with degree of malignancy in astrocytomas
Benedict Yan et al.
NEUROSCIENCE LETTERS (2006)
Oxidative stress regulated expression of ubiquitin carboxyl-terminal hydrolase-L1: Role in cell survival
H. Shen et al.
APOPTOSIS (2006)
Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines
U Rolén et al.
MOLECULAR CARCINOGENESIS (2006)
Ingenuity network-assisted transcription profiling:: Identification of a new pharmacologic mechanism for MK886
AL Mayburd et al.
CLINICAL CANCER RESEARCH (2006)
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer
Yasuo Miyoshi et al.
CANCER SCIENCE (2006)
PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma
T Takano et al.
EUROPEAN JOURNAL OF CANCER (2004)
Microarray expression analysis of gad mice implicates involvement of Parkinson's disease associated UCH-L1 in multiple metabolic pathways
M Bonin et al.
MOLECULAR BRAIN RESEARCH (2004)
Molecular mechanisms of tumor invasion and metastasis: An integrated view
RA Cairns et al.
CURRENT MOLECULAR MEDICINE (2003)
Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: An immunohistochemical study of 95 mesenchymal neoplasms
LK Campbell et al.
MODERN PATHOLOGY (2003)
Stimulation of the murine Uchl1 gene promoter by the B-Myb transcription factor
EM Long et al.
LUNG CANCER (2003)
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron
H Osaka et al.
HUMAN MOLECULAR GENETICS (2003)
The UCH-L1 gene encodes two opposing enzymatic activities that affect α-synuclein degradation and Parkinson's disease susceptibility
YC Liu et al.
CELL (2002)
Fibronectin in malignancy - Effect of aging
J Labat-Robert
SEMINARS IN CANCER BIOLOGY (2002)
Interaction and colocalization of PGP9.5 with JAB1 and p27Kip1
OL Caballero et al.
ONCOGENE (2002)
Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer
H Sasaki et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
